Strategic Partnerships Leverage their existing collaborations with top pharma players and recent partnerships (PathNet for 3D pathology diagnostics; Virdx for MRI-based cancer detection; Molecular Instruments for 3D RNA imaging) to identify co-selling or joint go-to-market opportunities and expand reach into preclinical and clinical programs.

3D Spatial Data Opportunity Position the Aurora 3D spatial biology platform as a gateway to providing intact tissue datasets and actionable spatial metrics for AI model training and validation, addressing pharma needs for ground-truth 3D data and more predictive decision-making across pipelines.

Clinical Diagnostics Tie‑ins Capitalize on 3D pathology-based diagnostic capabilities for cancer (prostate and bladder) to pursue dedicated pilot programs or CRO collaborations with pathology labs and biopharma groups seeking advanced diagnostic endpoints and patient stratification tools.

Awards and Visibility Utilize recent recognition in GeekWire Awards and BioCentury Grand Rounds to generate credibility in outreach efforts, inviting potential customers to case studies, webinars, and executive briefings focused on innovation and accelerated timelines.

Growth & Hiring Signal Target mid-market biotechs and CROs expanding teams in business development, wet lab, hardware, and software by offering scalable collaboration models, training, and joint development programs aligned with their capacity to adopt 3D imaging and AI analytics.